Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 37 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
60.00
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
1
x
$
30.00
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
1
x
$
30.00
Psychopharmacology Bulletin VOL 37 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 3 - Full Issue Stacked PDF
1
x
$
60.00
Genetics of Schizophrenia: Recent Advances
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
Intravenous Lidocaine Infusion for the Management of Early Postoperative Pain: A Comprehensive Review of Controlled Trials (OPEN ACCESS)
1
x
$
0.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
1
x
$
15.00
Pharmacology of Valproate
1
x
$
30.00
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
1
x
$
30.00
Treatment of Autism Spectrum Disorder in Children and Adolescents
1
x
$
30.00
Gary M. Levin, PharmD: A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Lasmiditan for the Treatment of Migraines With or Without Aura in Adults (OPEN ACCESS)
1
x
$
0.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
Vilazodone - Safety and Tolerability Profile PB VOL 44 No. 3
1
x
$
30.00
Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression
1
x
$
30.00
Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
0.00
Great Expectations in Stereochemistry: Focus on Antidepressants
1
x
$
0.00
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
1
x
$
30.00
View Cart
Checkout
Home
atypical-antipsychotics
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Metabolic Syndrome among Patients Taking Atypical Antipsychotics: A Comparative Cross-Sectional Study at Erada and Mental Health Complex in Taif, Saudi Arabia
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 4, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
The Utilization of Atypical Antipsychotics in the Pain Medicine Physician’s Armamentarium
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 3, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Risperidone Induced Isolated Thrombocytopenia: A Rare Adverse Event
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 38 Supplement No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Risperidone Induced Ventricular Tachycardia
$
30.00
Add to cart
Details
Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder
$
30.00
Add to cart
Details
Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial
$
30.00
Add to cart
Details
Ken Gersing, MD: Predicting Antipsychotic Use in Children
$
30.00
Add to cart
Details
Unmet Needs in the Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Late-Life Anxiety Disorders
$
30.00
Add to cart
Details
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
$
30.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
